Skip to main content
. 2019 Jun 20;9:8847. doi: 10.1038/s41598-019-45371-0

Table 2.

Number of reads obtained, retained after quality control, and mapped to the reference genome.

Treatment Replicate Total reads Reads after quality control Reads mapped to reference genome
Number Number % Number %
Control 1_gaII 38,623,190 38,595,804 99.93 36,658,295 94.98
Control 2_TruSeq_4 32,414,845 32,413,140 99.99 31,382,402 96.82
Control 6_TruSeq_6 28,893,141 28,891,426 99.99 27,923,563 96.65
Control 9_TruSeq_7 31,672,204 31,672,204 100.00 30,671,362 96.84
Hyd1 3_gaII 39,050,068 39,031,083 99.95 36,931,211 94.62
Hyd1 3_TruSeq_2 28,074,997 28,074,997 100.00 27,151,330 96.71
Hyd1 10_TruSeq_12 31,084,062 31,084,062 100.00 30,070,722 96.74
MSRO 2_gaII 36,838,900 36,824,546 99.96 34,640,850 94.07
MSRO 1_TruSeq_2 31,841,684 31,832,465 99.97 30,867,941 96.97
MSRO 5_TruSeq_5 30,537,077 30,535,822 100.00 29,442,640 96.42
MSRO 8_TruSeq_6 30,124,318 30,124,318 100.00 29,172,390 96.84
wMel 4_TruSeq_4 32,691,282 32,691,282 100.00 31,449,013 96.20
wMel 7_TruSeq_5 27,032,887 27,032,887 100.00 26,073,220 96.45
wMel 11_TruSeq_7 28,550,836 28,548,722 99.99 27,595,195 96.66